Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
1.930
+0.040 (2.12%)
At close: Sep 26, 2025, 4:00 PM EDT
1.940
+0.010 (0.52%)
After-hours: Sep 26, 2025, 4:10 PM EDT
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $91.43 million as of September 26, 2025. Its market cap has increased by 101.83% in one year.
Market Cap
91.43M
Enterprise Value
-85.77M
1-Year Change
101.83%
Ranking
Category
Stock Price
$1.93
Market Cap Chart
Since August 9, 2017, Whitehawk Therapeutics's market cap has decreased from $162.50M to $91.43M, a decrease of -43.74%. That is a compound annual growth rate of -6.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 91.40M | 17.48% |
| Dec 31, 2024 | 77.80M | 57.17% |
| Dec 29, 2023 | 49.50M | -84.19% |
| Dec 30, 2022 | 313.00M | -37.97% |
| Dec 31, 2021 | 504.60M | 992.21% |
| Dec 31, 2020 | 46.20M | 82.61% |
| Dec 31, 2019 | 25.30M | -63.33% |
| Dec 31, 2018 | 69.00M | -46.35% |
| Dec 29, 2017 | 128.60M | -20.86% |
| Aug 9, 2017 | 162.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.23B |
| Johnson & Johnson | 432.75B |
| AbbVie | 388.94B |
| UnitedHealth Group | 312.46B |
| Novo Nordisk | 242.68B |
| Novartis AG | 237.03B |
| Abbott Laboratories | 232.94B |
| AstraZeneca | 228.75B |